Hongxia Wang

3.7k citations
51 papers · 2.8k · 3 hit papers · h-index 22

Impact in

    • Cancer, Hypoxia, and Metabolism
  • Immunology top 5%
    • Immune cells in cancer
    • Neutrophil, Myeloperoxidase and Oxidative Mechanisms

Papers in

    • HER2/EGFR in Cancer Research 3
    • Cancer Cells and Metastasis 3
    • Cancer, Hypoxia, and Metabolism 3
    • MicroRNA in disease regulation 3

Hongxia Wang

49 papers receiving 2.8k citations

Hongxia Wang's Hit Papers

Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial 2024 · 91 citations
910+1+3Years since publication100200300400500

Peers

Hongxia Wang
Comparison fields: 5 of 112
  • Cancer Research 424
  • Immunology 550
  • Molecular Biology 1.5k
  • Oncology 447
  • Immunology and Allergy 61
Replace Davide Gianni with:
Davide Gianni United States
Diane E. Capen United States
Xiaoli Wu China
Shintaro Nakao Japan
Yasunori Shintani Japan
Annapaola Andolfo Italy
Cleo L. Bishop United Kingdom
Michele C. Madigan Australia
Xuan Cheng China
Thomas Carroll United States
Hongxia Wang relative to Davide Gianni United States Davide Gianni's profile →
Citations per field
00.5×2×3×3.5×
Davide Gianni · 1×
Citations per year

Countries citing papers authored by Hongxia Wang

Since Specialization
Citations

This map shows the geographic impact of Hongxia Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxia Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxia Wang more than expected).

Fields of papers citing papers by Hongxia Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongxia Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxia Wang. The network helps show where Hongxia Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Hongxia Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hongxia Wang Line = papers co-authored together Hongxia Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation
Hit paper breakdown →
2021505
2 2017411
3 2011323
4 2016158
5 2008142
6 202298
7
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
Hit paper breakdown →
202491
8 202082
9 201774
10 201773
11
TSPAN8 + myofibroblastic cancer–associated fibroblasts promote chemoresistance in patients with breast cancer
Hit paper breakdown →
202473
12 201868
13 201664
14 202260
15 202260
16 200955
17 201849
18 200648
19 202445
20 202138

About Hongxia Wang

Hongxia Wang is a scholar working on Oncology, Cancer Research, Molecular Biology, Cell Biology and Pulmonary and Respiratory Medicine, having authored 51 papers that have together received 2.8k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), Autophagy in Disease and Therapy (3 papers), Cancer Cells and Metastasis (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Extracellular vesicles in disease (3 papers), Ubiquitin and proteasome pathways (3 papers), Lung Cancer Treatments and Mutations (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (424 citations), Immunology (550 citations), Molecular Biology (1.5k citations), Oncology (447 citations) and Immunology and Allergy (61 citations). Hongxia Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Jun Zhou, Olivier Gires, Min Liu, Peter Ping Lin, Bin Wang, Quan Chen, Yushan Zhu, Lei Du, Dengwen Li and Cheng Cao. Their work appears in journals such as Journal of Biological Chemistry, Advanced Science, Oncogene, Cell Research and Journal of Hematology & Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact